- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03005041
Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects
May 21, 2018 updated by: GlaxoSmithKline
A Clinical Study Evaluating the Consumer Perception of an Experimental Mouthwash Formulation After a Single Use
The purpose of this study is to investigate the consumer perception of an experimental mouthwash formulation in population with dry mouth
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
56
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- GSK Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 84 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Demonstrates understanding of the study procedures, restrictions and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form
- Aged 18 - 84 years inclusive
- Good general and mental health with, in the opinion of the investigator or medically qualified designee no clinically significant and relevant abnormalities in medical history or upon oral examination
- Participant reports having a feeling of a dry mouth according to the Dry Mouth Screening Questionnaire (DMSQ) (Subject must answer at least 2 out of the 4 questions with 'agree a little', 'agree' or 'strongly agree' at the Screening Visit (Visit 1). Participants with un-stimulated whole salivary flow rate of ≤0.1 ml/min at the Screening Visit (Visit 1).
- Participants with un-stimulated whole salivary flow rate of ≤0.1 ml/min ATH the Screening Visit (Visit 1).
- Understands and is willing, able and likely to comply with all study procedures and restrictions
Exclusion Criteria:
- Women who are known to be pregnant or who are intending to become pregnant over the duration of the study or have a positive urine pregnancy test at the Screening Visit
- Women who are breast-feeding
- Participant is currently undergoing radiotherapy and/or chemotherapy treatment
- Any condition the investigator identifies that can confound the participant's ability to properly participate in the study e.g. Alzheimer's Disease
- Participant with untreated oral mucosal disease which in the opinion of the investigator could interfere with the study (e.g. current oral ulceration)
- Evidence of gross intra-oral neglect or need for extensive dental therapy
- Denture wearer (complete dentures)
- Participant not on stable doses of prescription systemic parasympathetic medications (e.g. Pilocarpine), for the treatment of the feeling of dry mouth
- Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients
- Participation in another clinical study (including cosmetic studies) or receipt of an investigational drug within 14 days of the screening visit
- Previous participation in this study
- Recent history (within the last 1 year) of alcohol or other substance abuse
- An employee of the sponsor or the clinical study team or members of their immediate family. Students and employees of the Tufts University School of Dental Medicine not associated with the clinical trials team are eligible to participate. Students and employees will not be specifically targeted for enrollment
- Non-English speaking Participants will not be enrolled in the study. Participants must be able to read and write in English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test Product 1
Participants will rinse their mouth with 15 mL of the product swishing for 30 seconds.
|
Participants will rinse their mouth with 15 mL of Biotene mouthwash swishing for 30 seconds.
|
Other: Test Product 2
Participants will rinse their mouth with 15 mL of the water swishing for 30 seconds.
Participants then spit out the water.
|
Participants will rinse their mouth with 15 mL of the water swishing for 30 seconds.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Response to Post-Product Use Questionnaires 1 (PPUQ 1); Question No.1
Time Frame: Within 2 minutes post product use
|
Participants answered the following question, Q1: how much do you agree or disagree with the following statements about this product, having used it?
"This product is gentle": disagree strongly, disagree, neither agree nor disagree, agree, or agree strongly.
There was no formal statistical hypothesis to be tested for this outcome..
|
Within 2 minutes post product use
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Response to Post-Product Use Questionnaires 1 (PPUQ 1); Question No. 3-7
Time Frame: Within 2 minutes post product use
|
Participants answered the following questions, Q3: Which of following statements best describes how much you liked product overall?
liked it-extremely, very much, somewhat, slightly, did not like it that much, did not like it at all.
Q 4: Which of the following statements best describes how much you liked overall flavor of rinse?
liked it-extremely, very much, somewhat, slightly, did not like it that much, did not like it at all.
Q 5: How you would rate flavor intensity of oral rinse?
strongest flavor imaginable, very strong, strong, moderate, weak, barely detectable, no flavor at all.
Q 6: Did you experience any of following sensations in your mouth & how strong was sensation?
moisturizing, soothing, refreshing, tingling, numbing, burning, or drying out.
Participants who selected "None" for a particular sensation, did not complete Q 7 for that sensation: When did you experience sensations in your mouth?
initially, during use, or after use.
|
Within 2 minutes post product use
|
Number of Participants With Response to Post-Product Use Questionnaires 2 (PPUQ 2)
Time Frame: Within 30 ± 5 minutes post product use
|
Participants answered the following question; Q1: Are you experiencing any of the following sensations in your mouth and how strong is the sensation?
moisturizing, soothing, refreshing, tingling, numbing, burning, or drying out.
Q2: Would you continue use of the product?
(Yes or No)
|
Within 30 ± 5 minutes post product use
|
Number of Participants With Response to Product Performance Attribute Questionnaire (PPAQ)
Time Frame: Within 5 minutes post product use
|
Participants rated the following criteria on a scale of 1 to 5(1=Poor, 2= Fair, 3= Good, 4= Very good, 5= Excellent) as follows: 1.
Having an immediate dry mouth relief, 2. Having an immediate lubricating effect, 3. Having an immediate moisturizing effect.
|
Within 5 minutes post product use
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 31, 2016
Primary Completion (Actual)
October 19, 2016
Study Completion (Actual)
October 19, 2016
Study Registration Dates
First Submitted
August 30, 2016
First Submitted That Met QC Criteria
December 23, 2016
First Posted (Estimate)
December 29, 2016
Study Record Updates
Last Update Posted (Actual)
July 19, 2018
Last Update Submitted That Met QC Criteria
May 21, 2018
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 205067
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Xerostomia
-
Cathrine RahbekDanish Cancer Society; DLHM - Danish Society for Mouth and Throat Cancer; Danish...Active, not recruitingXerostomia Following Radiotherapy | Xerostomia Following in Neck Ore Head After CancersurgeryDenmark
-
Institute of Oncology LjubljanaUniversity Medical Centre Ljubljana; University of Ljubljana; Blood Transfusion...Not yet recruitingXerostomia Following RadiotherapySlovenia
-
Catholic University of the Sacred HeartSunstar Italiana SRL.CompletedXerostomia | Xerostomia Following RadiotherapyItaly
-
Qazvin University Of Medical SciencesImam Khomeini HospitalCompletedRadiation-Induced XerostomiaIran, Islamic Republic of
-
Bedford Hospital NHS TrustUnknownXerostomia | Xerostomia Due to Radiotherapy | Xerostomia Due to Hyposecretion of Salivary Gland
-
Institut de Terapia Regenerativa TissularUnknownXerostomia Due to RadiotherapySpain
-
MeiraGTx, LLCActive, not recruitingRadiation-induced XerostomiaUnited States, Canada
-
Thomas KuhntVerband Deutscher DruckkammerzentrenTerminatedRadiation-induced XerostomiaGermany
-
Laboratoires CARILENEDERMSCAN-PHARMASCAN GROUP in charge of data analysisCompleted
Clinical Trials on Biotene mouthwash
-
GlaxoSmithKlineCompletedXerostomiaUnited States
-
University of California, Los AngelesRecruiting
-
SunBio, Inc.NAMSA; RudacureCompleted
-
St George Hospital, AustraliaCompleted
-
University of IowaEnrolling by invitationEdentulous Jaw | Edentulous MouthUnited States
-
Government Dental College and Research Institute...Himalaya Drug Company Research and Development, Makali, Bangalore, IndiaCompletedDentinal Hypersensitivity
-
Unither Pharmaceuticals, FranceCompletedHead and Neck Cancer | Xerostomia | Hyposalivation | Sjögren SyndromeFrance
-
University of Southern CaliforniaWithdrawnOveractive Bladder | Xerostomia | Compliance
-
Nova Scotia Health AuthorityDalhousie UniversityUnknownXerostomia | Hyposalivation
-
Rennes University HospitalNot yet recruiting